Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 h ago

Traws Pharma, Inc.: Chernett Jorey amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Chernett Jorey filed an amended Schedule 13G with the SEC disclosing a change in its beneficial ownership stake in Traws Pharma, Inc. (accession number 0000921895-26-003192). The filing updates the investor's previously reported position in the clinical-stage biopharmaceutical company. Schedule 13G amendments are typically required when passive investors cross or adjust threshold ownership levels, making the disclosure a signal of shifting institutional interest in the stock. Investors will watch for further 13G or 13D filings to gauge whether the position continues to change.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Traws Pharma, Inc., Chernett Jorey